Varian nets FDA nod

Radiation therapy vendor Varian Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its RapidArc radiotherapy technology.

The technology is designed to deliver image-guided intensity-modulated radiation therapy (IMRT) two to eight times faster than conventional IMRT or helical tomotherapy, according to the Palo Alto, CA-based vendor.

Related Reading

Varian buys Chinese distributor, December 26, 2007

Kyron inks deal with Varian, December 24, 2007

Varian gets FDA OK for scanning algorithm, December 14, 2007

Varian receives Swiss orders, December 12, 2007

Varian scores U.K. install, November 29, 2007

Copyright © 2008

Page 1 of 461
Next Page